As of 2026-09-20, the Relative Valuation of Acceleron Pharma Inc (XLRN) is (107.84) USD. This relative valuation is based on P/E multiples. With the latest stock price at 178.75 USD, the upside of Acceleron Pharma Inc based on Relative Valuation is -160.3%.
The range of the Relative Valuation is (103.75) - (112.28) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.5x - 26.6x | 23.8x |
| Forward P/E multiples | 24.6x - 27.6x | 27.3x |
| Fair Price | (103.75) - (112.28) | (107.84) |
| Upside | -158.0% - -162.8% | -160.3% |
| Date | P/E |